| Uptake and Removal of Uranium by and from Human Teeth A Younes, JS Ali, A Duda, C Alliot, S Huclier-Markai, J Wang, F Kabalan, ... Chemical Research in Toxicology 34 (3), 880-891, 2021 | 11 | 2021 |
| Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia JGW McCarter, D Nemirovsky, CA Famulare, N Farnoud, AS Mohanty, ... Blood Advances 7 (17), 5000-5013, 2023 | 10 | 2023 |
| Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma CR Tan, A Derkach, D Nemirovsky, A Ciardiello, B Diamond, M Hultcrantz, ... Blood Cancer Journal 13 (1), 112, 2023 | 8 | 2023 |
| Chemotherapy response in low‐grade serous ovarian carcinoma at a comprehensive cancer center: Readdressing the roles of platinum and cytotoxic therapies BL Manning‐Geist, RM Kahn, D Nemirovsky, J Girshman, A Laibangyang, ... Cancer 129 (13), 2004-2012, 2023 | 8 | 2023 |
| Molecular characterization of endometrial carcinomas in Black and White patients reveals disparate drivers with therapeutic implications B Weigelt, A Marra, P Selenica, E Rios-Doria, A Momeni-Boroujeni, ... Cancer discovery 13 (11), 2356-2369, 2023 | 7 | 2023 |
| Outcomes and management of the SARS-CoV2 omicron variant in recipients of hematopoietic cell transplantation and chimeric antigen receptor T cell therapy MS Infante, D Nemirovsky, S Devlin, S DeWolf, R Tamari, PB Dahi, YJ Lee, ... Transplantation and Cellular Therapy 30 (1), 116. e1-116. e12, 2024 | 6 | 2024 |
| Carfilzomib, lenalidomide and dexamethasone (KRd) vs bortezomib, lenalidomide, and dexamethasone (VRd) As induction therapy in newly diagnosed high-risk multiple myeloma C Tan, D Nemirovsky, A Derkach, M Hultcrantz, H Hassoun, S Mailankody, ... Blood 140 (Supplement 1), 1817-1819, 2022 | 6 | 2022 |
| Organ preservation and total neoadjuvant therapy for rectal cancer: Investigating long-course chemoradiation versus short-course radiation therapy. PB Romesser, BK Park, D Nemirovsky, J Alvarez, DM Omer, R Sarkar, ... Journal of Clinical Oncology 41 (4_suppl), 10-10, 2023 | 5 | 2023 |
| A pilot plant based dietary intervention in MGUS and SMM patients with elevated BMI is feasible and associated with improvements in metabolic and microbiome biomarkers of … UA Shah, A Derkach, F Castro, A Anuraj, J Blaslov, L Tran, PA Adintori, ... Blood 140 (Supplement 1), 5066-5069, 2022 | 5 | 2022 |
| Impact of exercise on chemotherapy-induced peripheral neuropathy in survivors with post-treatment primary breast cancer K Saint, D Nemirovsky, A Lessing, Y Chen, M Yang, WP Underwood, ... Breast Cancer Research and Treatment, 1-9, 2024 | 4 | 2024 |
| A Comparative Analysis of Infectious Complications in Patients with Multiple Myeloma Treated with BCMA-Targeted Bispecific Antibodies and CAR T-Cell Therapy K Nath, T Shekarkhand, BA Costa, D Nemirovsky, A Derkach, ... Blood 142, 1957, 2023 | 3 | 2023 |
| Comparison of Bendamustine Versus Fludarabine/Cyclophosphamide Lymphodepletion in Adult Patients Receiving CD19 CAR-T Cell Therapy I Landego, D Nemirovsky, SM Devlin, B Wills, A Parascondola, A Saldia, ... Blood 142, 3510, 2023 | 2 | 2023 |
| Evaluating the Effect of Evolving Changes in Serum Biomarkers on the Risk of Progression in Smoldering Multiple Myeloma T Akhlaghi, D Nemirovsky, KH Maclachlan, N Korde, S Mailankody, ... Blood 142, 877, 2023 | 1 | 2023 |
| Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in patients with T-and/or NK-cell lymphoma Y Liu, R Sardana, D Nemirovsky, D Frosina, A Jungbluth, WT Johnson, ... Blood Advances 8 (12), 3064-3075, 2024 | | 2024 |
| Colesevelam for Lenalidomide Associated Diarrhea in Patients with Multiple Myeloma M Hultcrantz, H Hassoun, N Korde, K Maclachlan, S Mailankody, D Patel, ... Research Square, 2024 | | 2024 |
| Virtual Biostats Day: An interactive online Biostatistics outreach program directed at high school students in groups historically underrepresented in STEM careers E Drill, JA Lavery, S Lobaugh, J Flynn, S Brown, H Kalvin, JF Chou, ... Journal of Statistics and Data Science Education, 1-18, 2024 | | 2024 |
| Real world incidence, prevention, and management of tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with venetoclax in the inpatient and outpatient … Y Valtis, D Nemirovsky, A Derkach, LE Roeker, S Sharan, C Kabel, R Ortiz, ... Journal of Clinical Oncology 42 (16_suppl), 7045-7045, 2024 | | 2024 |
| Comparison of infectious complications with BCMA-directed therapies in multiple myeloma K Nath, T Shekarkhand, D Nemirovsky, A Derkach, BA Costa, ... Blood Cancer Journal 14 (1), 88, 2024 | | 2024 |
| Costs to Medicare of Nonrecommended Bone-Modifying Agent Use for Castration-Sensitive Prostate Cancer AP Mitchell, D Nemirovsky, A Mishra Meza, N Chakraborty, S Persaud, ... JCO Oncology Practice 20 (3), 393-400, 2024 | | 2024 |
| Comparison of Infectious Complications with BCMA-directed Therapies in Multiple Myeloma A Lesokhin, K Nath, T Shekarkhand, D Nemirovsky, A Derkach, BA Costa, ... Research Square, 2024 | | 2024 |
